Orbital atherectomy for the treatment of severely calcified coronary lesions: evidence, technique, and best practices

E Shlofmitz, BJ Martinsen, M Lee, SV Rao… - Expert review of …, 2017 - Taylor & Francis
Introduction: The presence of severe coronary artery calcification is associated with higher
rates of angiographic complications during percutaneous coronary intervention (PCI), as …

Pivotal trial to evaluate the safety and efficacy of the orbital atherectomy system in treating de novo, severely calcified coronary lesions (ORBIT II)

JW Chambers, RL Feldman, SI Himmelstein… - JACC: Cardiovascular …, 2014 - jacc.org
Objectives: The ORBIT II (Evaluate the Safety and Efficacy of OAS in Treating Severely
Calcified Coronary Lesions) trial evaluated the safety and efficacy of the coronary Orbital …

Orbital atherectomy for treating de novo, severely calcified coronary lesions: 3-year results of the pivotal ORBIT II trial

M Lee, P Généreux, R Shlofmitz, D Phillipson… - Cardiovascular …, 2017 - Elsevier
Background/purpose The presence of heavy coronary artery calcification increases the
complexity of percutaneous coronary intervention (PCI) and increases the incidence of …

[HTML][HTML] Orbital atherectomy system in treating calcified coronary lesions: 3-Year follow-up in first human use study (ORBIT I trial)

P Bhatt, P Parikh, A Patel, M Chag… - Cardiovascular …, 2014 - Elsevier
Abstract Background/Purpose The ORBIT I trial evaluated the safety and performance of an
orbital atherectomy system (OAS) in treating de novo calcified coronary lesions. Severely …

[HTML][HTML] Orbital atherectomy for treating de novo severely calcified coronary narrowing (1-year results from the pivotal ORBIT II trial)

P Généreux, AC Lee, CY Kim, M Lee… - The American journal of …, 2015 - Elsevier
Percutaneous coronary intervention of severely calcified lesions has historically been
associated with major adverse cardiac event (MACE) rates as high as 30%. In the ORBIT II …

Safety and feasibility of orbital atherectomy for the treatment of calcified coronary lesions: the ORBIT I trial

K Parikh, P Chandra, N Choksi… - Catheterization and …, 2013 - Wiley Online Library
Objective: The ORBIT I trial evaluated the safety and performance of an orbital atherectomy
system (OAS) for the treatment of de novo calcified coronary lesions. Background: Severely …

Novel micro crown orbital atherectomy for severe lesion calcification: Coronary Orbital Atherectomy System Study (COAST)

B Redfors, SK Sharma, S Saito, AS Kini… - Circulation …, 2020 - Am Heart Assoc
Background: Percutaneous coronary intervention of severely calcified lesions carries a high
risk of adverse events despite the use of contemporary devices. The Classic Crown Orbital …

Orbital Atherectomy

E Shlofmitz - Updates in Percutaneous Coronary Intervention, An …, 2019 - books.google.com
Coronary artery calcification (CAC) negatively affects clinical outcomes after percutaneous
coronary intervention (PCI). 1, 2 Despite significant advances in device technology and …

[HTML][HTML] Patient selection and procedural considerations for coronary orbital atherectomy system

Y Sotomi, RA Shlofmitz, A Colombo… - Interventional …, 2016 - ncbi.nlm.nih.gov
Despite advances in technology, percutaneous coronary intervention (PCI) of severely
calcified coronary lesions remains challenging. Rotational atherectomy is one of the current …

Evaluation of the Diamondback 360 Coronary Orbital Atherectomy System for treating de novo, severely calcified lesions

JW Chambers, T Diage - Expert Review of Medical Devices, 2014 - Taylor & Francis
Coronary lesions with severe (or heavy) calcification are classified as complex lesions and
are known to carry lower success rates and higher complication rates following …